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Development of optimized conditions for Glaser-Hay 
bioconjugations
Zachary M. Nimmo, John F. Halonski, Lindsay E. Chatkewitz, and Douglas D. Young*
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Abstract
The efficient preparation of protein bioconjugates represents a route to novel materials, 
diagnostics, and therapeutics. We previously reported a novel bioorthogonal Glaser-Hay reaction 
for the preparation of covalent linkages between proteins and a reaction partner; however, 
deleterious protein degradation was observed under extended reaction conditions. Herein, we 
describe the systematic optimization of the reaction to increase coupling efficiency and decrease 
protein degradation. Two optimized conditions were identified varying either the pH of the 
reaction or the bidentate ligand employed, allowing for more rapid conjugations and/or less 
protein oxidation.
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1. Introduction
With widespread applications in the fields of medicine, materials, and pharmaceuticals, 
bioconjugate chemistry is a rapidly growing area of chemical research. Bioconjugates are 
comprised of a biological macromolecule linked to a second molecule, often a surface, 
probe, nanoparticle, or another biomolecule [1,2]. Protein bioconjugates, wherein at least 
one of the conjugate partners is a protein, have been utilized to enhance drug delivery and 
cellular imaging through the use of antibodies conjugated to cytotoxic drug molecules and 
luminescent quantum dots, in addition to numerous other applications [3–9].
The preparation of covalently-linked protein bioconjugates is often accomplished through 
reaction of a protein’s native nucleophilic residues, such as lysine, cysteine, and serine [10]. 
However, through this method, bioconjugation can occur at multiple residues within the 
protein, resulting in non-specific conjugation at a varying number of positions [10,11]. To 
overcome this lack of selectivity, unnatural amino acids (UAAs) can be site-specifically 
introduced into proteins via suppression of the amber stop codon (TAG) by an evolved 
orthogonal amino acyl synthetase (aaRS)/tRNA pair [12–14]. The incorporation of a UAA 
bearing a chemical moiety not found within the twenty naturally occurring amino acids not 
only provides a specific site for conjugation of the protein, but also allows access to several 
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useful conjugation methods previously unavailable for bioconjugation reactions involving 
proteins [15,16].
The Glaser-Hay coupling of two terminal alkynes is among these now-accessible protein 
bioconjugation reactions due to the preparation of a terminal alkyne containing UAA, p-
propargyloxyphenylalanine (pPrF, 1) [17]. This coupling reaction affords a well-defined, 
linear 1,3-diyne via a copper (I) catalyst and bidentate nitrogenous ligand (Fig. 1), most 
often N,N,N′,N′-tetramethyle thylenediamine (TMEDA, 2) [18–21]. Moreover, this 
generates a new carbon-carbon bond that is highly stable and unreactive under typical 
physiological conditions [18]. Diynes and other conjugated acetylenic structures generated 
from the Glaser-Hay coupling reaction have many useful applications. Such diynes are the 
starting point for many cycloaddition reactions yielding carbo- and heterocycles that display 
interesting biological, optoelectronic, and photochemical properties [22–26]. Additionally, 
the Glaser-Hay reaction can be utilized to generate diacetylenes employed in crystal-forming 
polymerization reactions [27], or to prepare classes of macrocyclic compounds with diverse 
applications in supramolecular chemistry and nanotechnology [28,29].
2. Materials and methods
2.1. Expression of GFP containing pPrF
A pET-GFP-TAG plasmid (0.5 µL) was co-transformed with a pEVOL-pPrF aaRS plasmid 
(0.5 µL) into Escherichia coli BL21 (DE3) competent cells using an Eppendorf Eporator 
electroporator. The cells were then plated (100 µL) on LB agar supplemented with 
ampicillin (50 µg/mL) and chloramphenicol (34 µg/mL), then incubated 16 h at 37 °C. One 
colony was used to inoculate LB media (10 mL) containing ampicillin and chloramphenicol. 
The culture was incubated overnight at 37 °C and used to initiate an expression culture (250 
mL media, ampicillin 50 µg/mL, chloramphenicol 34 µg/mL) at an OD600 = 0.1. The 
cultures were incubated at 37 °C to an OD600 = 0.6. Protein expression was induced by 
addition of 20% arabinose (250 µL), 0.8 mM isopropyl-β-D-1-thiogalactopyra noside 
(IPTG; 250 µL), and pPrF (1) (2.5 mL, 100 mM). Cultures were incubated at 30 °C 
overnight, then pelleted by centrifugation (5000 rpm, 10 min). Pelleted cells were stored at 
−80 °C until purification. The cell pellet was resuspended with 500 µL of Bug-buster 
(Novagen), and 200 µL of lysis buffer and incubated for 20 mins at 37 °C. Cellular debris 
was pelleted out by centrifugation at 5000 rpm for 10 mins and the supernatant was added to 
an equilibrated Ni-NTA resin (200 µL). GFP was purified according to manufacturer’s 
protocol before being analyzed by SDS-PAGE (BioRad 10% precast gels, 150 V, 1.5 h). 
Gels were stained using Coomassie Brilliant Blue, and destained using destain solution 
(60% deionized H2O, 30% MeOH, 10% acetic acid).
2.2. Biological Glaser-Hay reaction under optimized condition 1
To a sterile 1.5 mL eppendorf tube, the following were added: 5 µL of a vigorously shaken 
solution of CuI (500 mM in H2O) and 5 µL of tetramethylethylenediamine (2 in 500 mM in 
H2O). The two solutions were thoroughly mixed by pipetting. Next, 30 µL of GFP 
containing a terminal alkyne UAA (GFP/pPrF; pH = 6.0, 1.04 ± 0.0 3 mg/mL) and 20 µL of 
AlexaFluor-488 Alkyne (1 mM in DMSO) were added to the tube. The reaction was 
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incubated at room temperature (22 °C). After 4 h, excess reactants were removed by buffer 
exchange using Spin-X UF concentrator columns. The reaction was washed with PBS (8 × 
200 µL) to a final volume of 50 µL. The reaction was analyzed by SDS-PAGE and imaged 
immediately to analyze fluorescence. The gel was then stained for 3 h using Coomassie 
Brilliant Blue, then destained overnight using a methanol solution (60% deionized H2O, 
30% MeOH, 10% acetic acid). The gel was then analyzed again on the gel imager.
2.3. Biological Glaser-Hay reaction under optimized condition 2
To a sterile 1.5 mL eppendorf tube, the following were added: 5 µL of a vigorously shaken 
solution of CuI (500 mM in H2O) and 5 µL of 2,2′-Bipyridine-4,4′-dicarboxylic acid (10, 
500 mM in 1 M NaOH). The two solutions were thoroughly mixed by pipetting until a dark 
brown color was achieved. Next, 30 µL of GFP containing a terminal alkyne UAA (GFP/
pPrF; pH = 8.0, 1.04 ± 0.03 mg/mL) and 20 µL of AlexaFluor-488 Alkyne (1 mM in 
DMSO) were added to the tube. The reaction was incubated at room temperature (22 °C). 
After 8 h, excess reactants were removed by buffer exchange using Spin-X UF concentrator 
columns. The reaction was washed with PBS (8 × 200 µL) to a final volume of 50 µL. The 
reaction was analyzed by SDS-PAGE and imaged immediately to analyze fluorescence. The 
gel was then stained for 3 h using Coomassie Brilliant Blue, then destained overnight using a 
methanol solution (60% deionized H2O, 30% MeOH, 10% acetic acid). The gel was then 
analyzed again on the gel imager.
3. Results and discussion
Transferring the Glaser-Hay coupling to a biological setting for use in bioconjugations 
necessitates relatively mild reaction conditions that are compatible with physiological 
systems, namely a moderate temperature, aqueous environment, and short reaction time. 
Several past experiments have successfully employed the Glaser-Hay reaction on 
biologically relevant molecules, though not necessarily under mild conditions. In 2015, 
oxidative coupling of terminal alkynes was reported with the formation of peptoid dimers at 
90 °C in DMSO, and again with macrocyclization of tetrapeptides at 60 °C using Cu(OAc2) 
and NiCl2 catalysts [30,31].
Our previous work demonstrated the first successful biological Glaser-Hay coupling in a 
full-length protein and under mild reaction conditions (Fig. 1C) [32–34]. With incorporation 
of pPrF into green fluorescent protein (GFP), we generated a protein-fluorophore 
bioconjugate at 4 °C after 4 h. Despite having successfully employed the Glaser-Hay 
coupling in a biological context, we observed noticeable protein degradation after about 6 h. 
We proposed that this degradation was potentially due to hydroxyl radicals generated from 
the copper (II)-hydroxyl intermediate in the catalytic cycle of the Glaser-Hay reaction, 
which is known to be deleterious to living systems [19,35]. This protein oxidation was 
characterized by MS analysis, ultimately resulting in loss of protein product (See Supporting 
Information). To avoid protein degradation, we became interested in developing means to 
circumvent the production of harmful radical species while generating the same internal 1,3-
diyne structure. One such method that we developed implemented the Cadiot-Chodkiewicz 
coupling of a terminal alkyne and halo-alkyne to afford a protein-fluorophore bioconjugate 
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[36]. Because the Cadiot-Chodkiewicz mechanism is thought to cycle between the copper (I) 
and copper (III) states while avoiding the harmful copper (II) state, reaction times could be 
extended with minimal protein degradation [37]. Furthermore, under the Cadiot-
Chodkiewicz mechanism, we were able to reduce the amount of catalytic copper ten-fold 
from that required by the Glaser-Hay mechanism and achieve satisfactory coupling. While 
the Cadiot-Chodkiewicz coupling occurred with less protein degradation, it did require 
additional synthetic steps to access bromoalkyne amino acids or brominated coupling 
partners. Because the terminal alkyne amino acid is commercially available, and an 
orthogonal aaRS/tRNA pair has specifically been evolved to incorporate it, the Glaser-Hay 
coupling is more easily accessible. Thus, we aim to systematically optimize the traditional 
Glaser-Hay reaction to increase coupling efficiency and preserve protein from degradation, 
allowing it to find more widespread utility.
In order to further optimize the biological Glaser-Hay reaction, a 250 mL expression of GFP 
harbouring pPrF in position 151 was performed to ensure that all reactions were conducted 
on the same protein batch (1.0 mg/mL) to remove variability between expressions. With the 
pPrF-GFP in hand, a range of experimental variables was examined in a systematic fashion 
when reacting the mutant GFP with an AlexaFluor-488 alkyne dye. Due to the production of 
biologically deleterious Cu(II) in the catalytic cycle, we examined the addition of both 
reducing agents and radical scavengers to the reaction as a mechanism to mitigate the 
potential damage caused by the radicals initiated by the Cu(II) species. Additionally, we 
examined the effects of a wide variety of copper sources and ligands to further activate the 
copper center, as well as buffers at varying pH. Each variable was independently varied 
based on the previously reported conditions, and optimized conditions were then screened in 
combination to elucidate the best Glaser-Hay bioconjugation conditions.
Initial studies examined the addition of reducing agents to the reaction to reduce harmful 
Cu(II) back to the Cu(I) species. Based on their biological compatibility, β-mercaptoethanol, 
tris(2-carboxyethyl)phosphine (TCEP), dithiothreitol (DTT) and nicotinamide adenine 
dinucleotide (NADH) were selected for analysis. Glaser-Hay reactions were conducted with 
the pPrF-GFP and AlexaFluor-488 alkyne in the presence of a reducing agent (500 mM), 
TMEDA and CuI for 4 h at 4 °C. Control reactions were also performed in the absence of 
reducing agent, or in the absence of the CuI/TMEDA. After purification and buffer 
exchange, the reactions were analyzed by SDS-PAGE for protein degradation and coupling 
efficiency. Fluorescence intensity indicated the effective coupling reaction as the GFP is 
denatured and no longer fluorescent, while the coupling to the fluorophore re-establishes a 
fluorescent signal. Coomassie staining was also performed to indicate protein presence and 
relative degradation. Unfortunately, no reducing agent afforded better coupling conditions 
than the original conditions, and DTT dramatically inhibited efficient coupling (see 
Supporting Information, Fig. 1). Similar results were observed when radical scavengers were 
employed including cysteine, oleic acid, and ascorbic acid. Ascorbic acid also hindered the 
Glaser-Hay reaction from occurring and increased the level of protein degradation (see 
Supporting Information, Fig. 1).
Based on the literature, a variety of copper sources have been utilized in the Glaser-Hay 
reaction, and we next investigated if any were more advantageous than the previously 
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reported copper iodide. Reactions were performed using copper(I) iodide, copper(I) 
chloride, copper(II) chloride, and copper(II) sulfate. Reactions were additionally performed 
using copper(II) chloride with nicotinamide adenine dinucleotide and copper(II) sulfate with 
nicotinamide adenine dinucleotide to test whether a copper(II) catalyst reduced to copper(I) 
would be advantageous for the reaction. None of these copper sources were able to 
outperform the previously established CuI, as determined by SDS-PAGE (see Supporting 
Information, Fig. 3).
We next investigated the effect of the ligand on the Glaser-Hay bioconjugation. Early 
attempts with nitrogenous monodentate ligands (TEA, pyrrolidine, etc.) did not lead to 
substantial coupling, and a more thorough investigation of bidentate nitrogenous ligands 
followed (see Fig. 2). Ligands 3 and 4 were selected to investigate the optimal chelation ring 
size, and 5, 6, and 7 were employed to probe the substitution of the nitrogen atom. Finally, 8 
and 9 were selected to alter the electronic environment of the nitrogen atoms, while 
simultaneously testing the necessity of chelation. These experiments indicated that both the 
2,2-bipyridyl ligand (8) and the diaminopropane ligand (3), to a much lesser extent, were as 
good as or better than 2, with 4-fold and 0.8–1.2-fold increases in coupling efficiency, 
respectively. However, 8 had limited solubility in aqueous media, so the commercially 
available 10 was explored to overcome these issues. Gratifyingly, 10 afforded a coupling 
effiency nearly 7 times greater than that of 2. We hypothesize that the combination of the 
electronic effects of the bipyridyl ligand coupled with the rigidity of the ligand aided in the 
chelation and activation of the copper center to improve the reaction.
After elucidating that ligand 10 resulted in superior coupling, we explored whether other 
copper sources, radical scavengers, or reducing agents would further increase the coupling 
efficiency with these ligands. Varying these other conditions did not afford enhanced results, 
as copper(I) iodide with no added agents remained the best condition using either 2 or 10.
The next variable examined was the effect of solution pH on the reaction. GFP was buffer 
exchanged into PBS at pH 6.0, pH 7.0, pH 8.0, and pH 9.0. Both the original ligand (2) and 
10 were used for Glaser-Hay couplings in each pH solution. Interestingly, reactions 
employing 2 exhibited higher coupling ratios at pH 6.0, and reactions with 10 had the 
highest Glaser-Hay coupling at pH 8.0. Additionally, less degradation of protein was 
observed under both of these new conditions, as observed by comparable amounts of protein 
on the gels as the control reactions, and minimized oxidative damage by MS. Due to the 
decreased oxidative damage, we then employed these conditions at different temperatures to 
see if coupling ratios could be increased further, as the previously published conditions were 
performed at 4 °C to minimize degradation. Identical reactions with both ligands were 
conducted at 4, 22, 30, and 37 °C for 4 h. After quantitation by SDS-PAGE, the most 
effective coupling condition with the least amount of protein degradation was found to be 
room temperature (22 °C) for both ligands. As a final optimization, the two ligands were 
employed at their appropriate pH and at room temperature over a timespan of 24 h (Fig. 3). 
The results indicate that for both conditions, protein degradation begins to become a factor 
after approximately 8 h, leading to a subsequent decrease in Glaser-Hay bioconjugations. 
The timecourse experiments also reveal that the conjugations employing 10 result in less 
overall protein degradation relative to both conditions using 2. This decreased degradation 
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allows for increased reaction times, that facilitate higher levels of coupling. In the case of 2, 
lowering the pH to 6.0 appears to accelerate the reaction rate, improving coupling prior to 
degradation.
Ultimately, we elucidated two optimized conditions that improved coupling efficiency and/or 
minimized protein degradation, resulting in yields of ~95% or greater as determined by 
absorbance spectroscopy. For ligand 2, reactions performed at 22 °C, pH 6.0, for 4 h 
afforded the best results, while 10 functioned best at 22 °C, pH 8.0, for 8 h (Fig. 4). Each of 
these conditions facilitates substantial improvement over the previously published conditions 
of 2, 4 °C, pH 7.4, for 4 h. Selection of appropriate ligand is most likely application 
dependent, as 2 affords shorter reaction times to obtain the bioconjugate, while 10 provides 
slower couplings, but with less protein degradation.
4. Conclusion
In conclusion, two new reaction conditions have been developed towards optimizing Glaser-
Hay bioconjugations. The ability to increase coupling efficiency, while simultaneously 
decrease harmful protein degradation, increases the overall utility of this reaction. 
Expanding the chemical toolbox of bioorthogonal bioconjugations is essential towards the 
preparation of various conjugates having medical and materials based applications. The 
Glaser-Hay reaction in particular is unique in its installation of a linear, carbon-carbon 
covalent bond, which also facilitates secondary reactions from the diyne moiety. Either 
lowering the pH with the traditional TMEDA ligand, or employing a carboxylated biphenyl 
ligand generates more efficient couplings with less degradation than the previously reported 
conditions.
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Fig. 1. 
Glaser-Hay reactions. (A) Structure of alkynyl amino acid pPrF incorporated into proteins. 
(B) General Glaser-Hay reaction linking two terminal alkynes. (C) Glaser-Hay 
bioconjugation of a protein.
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Fig. 2. 
Structures of ligands employed in Glaser-Hay bioconjugation optimization.
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Fig. 3. 
Timecourse data for optimized Glaser-Hay bioconjugations demonstrating coupling 
efficiency (line) in combination with protein degradation (bars). (A) Timecourse of the 
Glaser-Hay bioconjugation with ligand 10, pH 8. (B) Timecourse of the Glaser-Hay 
bioconjugation with ligand 2, pH 6. All reactions were conducted in triplicate to establish 
appropriate standard deviations.
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Fig. 4. 
Optimized Glaser-Hay Bioconjugations. (A) SDS-PAGE analysis of the best conditions for 
the bioconjugation compared to a negative control (lane 1) and the previously reported 
conditions (lane 2). The fluorescence (bottom gel) indicates degree of fluorophore coupling 
and the coomassie stain (top gel) indicates relative protein concentrations. Ultimately 2, pH 
6, 4 h (lane 3) and ligand 10, pH 8, 8 h (lane 4) afforded the highest bioconjugate yields with 
minimal protein degradation. (B) Graphical representation of the gel densiometry analysis 
performed on three independent SDS-PAGE experiments quantifying the optimized 
conditions.
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